HÉPARTICHAUT OTC
Natural health product licensed in Canada
- Licence holder
- BioPharma Ltée
- NPN or DIN-HM
- 80031107
- Status
- Active licence
- Licence date
- 30 March 2012
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Cynara scolymus Source : Feuille Extraction ratio : 4:1 Dry plant equivalent : 2,000 mg | 500 mg | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, Microcrystalline cellulose, Gélatine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 3 Tous les jours |
Uses authorised in Canada
Utilisé en phytothérapie pour aider à soulager les troubles digestifs, tels que la dyspepsie. Utilisé en phytothérapie pour aider à stimuler la sécrétion de la bile (cholérétique).
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consulter un praticien de soins de santé avant d'en faire l'usage si vous aves des calculs billaires. Consulter un praticien de soins de santé avant d'en faire l'usage si vous êtes enceinte. Consulter un praticien de soins de santé si les symptômes persistent ou s'aggravent.
- Contre-indications
Ne pas utiliser en cas d'allergie à la famille des Astéracées/Composées/Marguerites. Ne pas utiliser si vous avez une obstruction de la voie billaire.
- Effets indésirables connus
Une hypersensibilité (e.g. une allergie) peut se manifester. Si tel est le cas, cesser l'utilisation.
Source
Official Health Canada record, licence 80031107
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.